World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
18585
World Ranking
19839
National Ranking
9883

Eric Jonasch publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eric Jonasch sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 538 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eric Jonasch D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eric Jonasch sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eric Jonasch is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a notable focus on cancer-related studies. Their work incorporates clinical and molecular aspects related to cancer treatment and biology.

The scientist's research is situated primarily within these main fields of study:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these disciplines, they have contributed extensively to subfields including:

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Oncology
  • Surgery

Eric Jonasch's published work addresses several core topics such as:

  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Bladder and Urothelial Cancer Treatments
  • Pancreatic and Hepatic Oncology Research

Their recent published papers include:

  • Clear cell renal cell carcinoma ontogeny and mechanisms of lethality, 2020, Nature Reviews Nephrology
  • High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types, 2021, Annals of Oncology
  • Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages, 2021, Cell
  • Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis, 2021, Nature Medicine
  • Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network

Eric Jonasch frequently collaborates with other researchers, notably:

  • Nizar M. Tannir
  • Pavlos Msaouel
  • Matthew T. Campbell
  • Amishi Y. Shah
  • José A. Karam

The scientist has published numerous articles in several key journals, including:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • The Oncologist
  • Journal of the National Comprehensive Cancer Network
  • Clinical Cancer Research

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.

    DJ McGrail;PG Pilié;NU Rashid;L Voorwerk

  • Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities

    Eric Jonasch;Frank G. Haluska

  • Renal cell carcinoma

    Eric Jonasch;Jianjun Gao;W Kimryn Rathmell

  • NCCN clinical practice guidelines in oncology: kidney cancer.

    Robert J Motzer;Neeraj Agarwal;Clair Beard;Graeme B Bolger

  • Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    Robert J Motzer;Eric Jonasch;Neeraj Agarwal;Sam Bhayani

  • Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.

    Eric Jonasch;Cheryl Lyn Walker;W. Kimryn Rathmell

  • Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

    Lijun Zhou;Xian-De Liu;Mianen Sun;Xuesong Zhang

  • Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

    Nizar M. Tannir;Eric Jonasch;Laurence Albiges;Emre Altinmakas

  • The PI3K/AKT Pathway and Renal Cell Carcinoma

    Huifang Guo;Peter German;Shanshan Bai;Sean Barnes

  • Featured Updates to the NCCN Guidelines

    Robert J. Motzer;Eric Jonasch;M. Dror Michaelson;Lakshminarayanan Nandagopal

  • Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline

    Sherri M. Donat;Mireya Diaz;Jay Todd Bishoff;Jonathan A. Coleman

  • Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines

    Robert J. Motzer;Eric Jonasch;Neeraj Agarwal;Clair Beard

  • Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

    Brian I Rini;Bohuslav Melichar;Takeshi Ueda;Viktor Grünwald

  • Dual Chromatin and Cytoskeletal Remodeling by SETD2.

    In Young Park;Reid T. Powell;Durga Nand Tripathi;Ruhee Dere

  • Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.

    Eric Jonasch;Frede Donskov;Othon Iliopoulos;W Kimryn Rathmell

  • Kidney cancer, version 1.2021: Featured updates to the nccn guidelines

    Robert J. Motzer;Eric Jonasch;Shawna Boyle;Maria I. Carlo

Frequent Co-Authors

Nizar M. Tannir
Nizar M. Tannir The University of Texas MD Anderson Cancer Center
Christopher G. Wood
Christopher G. Wood The University of Texas MD Anderson Cancer Center
Surena F. Matin
Surena F. Matin The University of Texas MD Anderson Cancer Center
Pheroze Tamboli
Pheroze Tamboli The University of Texas MD Anderson Cancer Center
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Toni K. Choueiri
Toni K. Choueiri Harvard University
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Cheryl L. Walker
Cheryl L. Walker Baylor College of Medicine
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Elizabeth R. Plimack
Elizabeth R. Plimack Fox Chase Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related healthcare fields can provide valuable pathways for those interested in a medical career or seeking flexible study options. For example, adn nursing programs (Associate Degree in Nursing) are an accessible way to begin a nursing career quickly, and may have lower entry barriers compared to traditional MD programs.

Many students are also interested in healthcare roles that don’t require direct patient care. Accredited medical billing and coding schools that accept fafsa offer online programs with financial aid, opening the door to administrative roles in the healthcare system.

If test anxiety is a concern, some nursing schools that don’t require teas or hesi make it easier for applicants by eliminating entrance exam requirements, streamlining the admissions process.

For those seeking fast-track leadership roles, a health administration degree can be completed online in an accelerated format, preparing graduates for management careers in hospitals, clinics, and healthcare organizations.

Best Scientists Citing Eric Jonasch

Trending Scientists

Recently Published Articles